Home » Topics » Regulatory » NMPA

NMPA
RSS

Chinese authorities approve clinical trials of ZKAB-001

Jan. 30, 2018

China FDA accepts IND for Ascentage's IAP inhibitor

Jan. 9, 2018

CFDA designates lenvatinib for priority review and approval for HCC

Dec. 28, 2017

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Dec. 28, 2017

Ebola vaccine approved in China

Oct. 26, 2017

Fosun Pharma reports Chinese IND application for FCN-437c

July 19, 2017

CStone cleared to begin clinical trials of CS-1001 in China

July 18, 2017

China FDA accepts fruquintinib NDA for advanced colorectal cancer

June 12, 2017

Tagrisso approved in China for NSCLC

March 27, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...